Bioventus (BVS) Operating Income Growth (1y) (2021 - 2026)
Bioventus (BVS) Operating Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 74.18% |
| 10 | Bioventus | 837.84 Mn | 801.99 Mn | 90.77 Mn | 72.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 72.85% |
| Dec 31, 2025 | 152.97% |
| Sep 27, 2025 | 208.53% |
| Jun 28, 2025 | 158.36% |
| Mar 29, 2025 | -1.20% |
| Dec 31, 2024 | 561.20% |
| Sep 28, 2024 | 50.83% |
| Jun 29, 2024 | -566.27% |
| Mar 30, 2024 | 105.35% |
| Dec 31, 2023 | 107.45% |
| Sep 30, 2023 | 101.91% |
| Jul 1, 2023 | 304.05% |
| Apr 1, 2023 | -329.17% |
| Dec 31, 2022 | -396.41% |
| Oct 1, 2022 | -12,014.52% |
| Jul 2, 2022 | 42.37% |
| Apr 2, 2022 | -197.51% |
| Dec 31, 2021 | -153.32% |
| Oct 2, 2021 | -115.10% |
| Jul 3, 2021 | -24.97% |